{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:10:46Z","timestamp":1750479046751},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Gen Psychiatry"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1744-859x-6-11","type":"journal-article","created":{"date-parts":[[2007,5,2]],"date-time":"2007-05-02T11:23:27Z","timestamp":1178105007000},"source":"Crossref","is-referenced-by-count":7,"title":["Intramuscular Olanzapine \u2013 a UK case series of early cases"],"prefix":"10.1186","volume":"6","author":[{"given":"Chris J","family":"Bushe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,1]]},"reference":[{"key":"568_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0165-1781(03)00107-0","volume":"119","author":"S Lindborg","year":"2003","unstructured":"Lindborg S, Beasley C, Alaka K, Taylor C: Effects of intramuscular olanzapine versus haloperidol and placebo on QTc intervals in acutely agitated patients. Psychiatry Research. 2003, 119: 113-123. 10.1016\/S0165-1781(03)00107-0.","journal-title":"Psychiatry Research"},{"issue":"Suppl 2","key":"568_CR2","first-page":"22","volume":"62","author":"B Jones","year":"2001","unstructured":"Jones B, Taylor C, Meehan K: The efficacy of a rapid acting formulation of intramuscular olanzapine for positive symptoms. J Clin Psychiatry. 2001, 62 (Suppl 2): 22-24.","journal-title":"J Clin Psychiatry"},{"key":"568_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0735-6757(02)42249-8","volume":"21","author":"J Battaglia","year":"2003","unstructured":"Battaglia J, Lindborg S, Alaka K, Meehan K, Wright P: Calming versus sedative effects of intramuscular olanzapine in agitated patients. Am J Emerg Med. 2003, 21: 192-198. 10.1016\/S0735-6757(02)42249-8.","journal-title":"Am J Emerg Med"},{"key":"568_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/088506668600100304","volume":"1","author":"G Tesar","year":"1986","unstructured":"Tesar G, Stern T: Evaluation and treatment of agitation in the intensive care unit. J Intens Care Med. 1986, 1: 137-148.","journal-title":"J Intens Care Med"},{"key":"568_CR5","first-page":"4","volume":"27","author":"Anonymous","year":"2001","unstructured":"Anonymous: QT prolongation with antipsychotics. Current problems in pharmacovigilance. 2001, 27: 4-","journal-title":"Current problems in pharmacovigilance"},{"issue":"Suppl 3","key":"568_CR6","first-page":"16","volume":"61","author":"WM Glazer","year":"2000","unstructured":"Glazer WM: Extrapyramidal side effects, tardive dyskinesia and the concept of atypicality. J Clin Psychiatry. 2000, 61 (Suppl 3): 16-21.","journal-title":"J Clin Psychiatry"},{"key":"568_CR7","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","volume":"158","author":"P Wright","year":"2001","unstructured":"Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, Saunders JC, Krueger J, Bradley P, San L, Bernardo M, Reinstein M, Breier A: Double blind placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry. 2001, 158: 1149-1151. 10.1176\/appi.ajp.158.7.1149.","journal-title":"Am J Psychiatry"},{"key":"568_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","volume":"21","author":"K Meehan","year":"2001","unstructured":"Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, Koch M, Rizk R, Walker D, Tran P, Brier A: A double blind randomised comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacology. 2001, 21: 389-397. 10.1097\/00004714-200108000-00006.","journal-title":"J Clin Psychopharmacology"},{"key":"568_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/schbul\/16.3.537","volume":"16","author":"SR Kay","year":"1990","unstructured":"Kay SR, Sevy S: Pyramidical model of schizophrenia. Schizophrenia Bulletin. 1990, 16: 537-545.","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"568_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schiz Bull. 1987, 13 (2): 261-276.","journal-title":"Schiz Bull"},{"issue":"2","key":"568_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2165\/00023210-200519020-00005","volume":"19","author":"A Wagstaff","year":"2005","unstructured":"Wagstaff A, Easton J, Scott L: Intramuscular Olanzapine \u2013 a review of its use in the management of acute agitation. CNS Drugs. 2005, 19 (2): 147-164. 10.2165\/00023210-200519020-00005.","journal-title":"CNS Drugs"}],"container-title":["Annals of General Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-859X-6-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1744-859X-6-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1744-859X-6-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T11:49:54Z","timestamp":1548157794000},"score":1,"resource":{"primary":{"URL":"https:\/\/annals-general-psychiatry.biomedcentral.com\/articles\/10.1186\/1744-859X-6-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1186\/1744-859x-6-11","relation":{},"ISSN":["1744-859X"],"issn-type":[{"value":"1744-859X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,1]]},"article-number":"11"}}